Sipahi, I. Et Al. 2014. A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran. JAMA INTERNAL MEDICINE , vol.174, no.1 , 150-151.

Sipahi, I., Celik, S., & Tozun, N., (2014). A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran. JAMA INTERNAL MEDICINE , vol.174, no.1, 150-151.

Sipahi, Ilke, Seden Celik, And Ayşe Nurdan TÖZÜN. "A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran," JAMA INTERNAL MEDICINE , vol.174, no.1, 150-151, 2014

Sipahi, Ilke Et Al. "A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran." JAMA INTERNAL MEDICINE , vol.174, no.1, pp.150-151, 2014

Sipahi, I. Celik, S. And Tozun, N. (2014) . "A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran." JAMA INTERNAL MEDICINE , vol.174, no.1, pp.150-151.

@article{article, author={Ilke Sipahi Et Al. }, title={A Comparison of Results of the US Food and Drug Administration's Mini-Sentinel Program With Randomized Clinical Trials: The Case of Gastrointestinal Tract Bleeding With Dabigatran}, journal={JAMA INTERNAL MEDICINE}, year=2014, pages={150-151} }